Hongcheng Biopharma discovers, develops and manufactures innovative therapeutic products. The company’s portfolio is comprised of multifunctional antibodies, ADC, prodrugs to treat cancer and autoimmune diseases, representing a combination of synergistic agents to deliver curative patient outcomes.